Sign Up to like & get
recommendations!
1
Published in 2020 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-020-04067-3
Abstract: Purpose Fedratinib is an orally administered Janus kinase 2-selective inhibitor that is indicated for the treatment of adult patients with intermediate-2 or high-risk myelofibrosis in the United States. Fedratinib is metabolized by multiple cytochrome P450s…
read more here.
Keywords:
fedratinib;
oral doses;
oral dose;
dose fedratinib ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-020-04074-4
Abstract: Purpose Fedratinib, an oral, selective Janus kinase 2 inhibitor with activity against both wild-type and mutant Janus kinase 2, has pH-dependent solubility, with free solubility at pH 1. Concomitant administration of drugs that reduce gastric…
read more here.
Keywords:
healthy male;
study;
male subjects;
doses pantoprazole ... See more keywords